Drug recall · August 14, 2013
Terazosin Hydrochloride Capsules recall
Why: Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-4339-01
- Lots / codes
Lot # N07321, Exp 6/14
- Quantity
- 6267 bottles
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide and Puerto Rico
- Initiated
- July 23, 2013 · Voluntary: Firm initiated
- Classified
- August 6, 2013
- Reported
- August 14, 2013
- Ended
- August 27, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Terazosin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.